We verified the effects of ruthenium-fluvastatin complex treatment on various proteins like PI3K, Akt, mTOR, EGFR, VEGF, and cleaved caspase-3 in MCF-7 and MDA-MB-231 human breast cancer cells. The gene discussed is VEGFA; the disease is breast carcinoma.